Cannabis & Women's Health Switzerland: PMS, Endometriosis, Menopause | CannabisClub.ch

How does cannabis affect women? Endocannabinoid system, cycle, PMS, endometriosis, menopause — plus Swiss legal status and interactions with pill and HRT.

Women experience cannabis differently than men — hormonally, metabolically and in effect. Yet women's health remains largely under-illuminated in the Swiss cannabis debate. This guide covers how the female endocannabinoid system interacts with the cycle, what studies say about PMS, endometriosis and menopause, which CBD/THC uses are legal in Switzerland, and the warnings (pregnancy, pill, breastfeeding) to observe.

Important: This article is not a substitute for medical advice. Cannabis (incl. CBD) is generally not recommended in pregnancy or breastfeeding. Consult your doctor for existing conditions or medications.

TL;DR — Cannabis & women's health Switzerland

Women & the endocannabinoid system

The endocannabinoid system (ECS) regulates pain, mood, sleep, appetite, immune response — and in women is hormonally modulated. Studies (Craft et al. 2013, Fattore & Fratta 2010) show estrogen increases anandamide activity, while progesterone lowers it. Practical consequence: cannabis can feel different across cycle phases.

Cycle phases & cannabinoids

PMS & menstrual cramps

Premenstrual syndrome (PMS) and dysmenorrhoea affect up to 80 % of women. Full-spectrum CBD acts via multiple mechanisms: prostaglandin modulation, TRPV1 activation, serotonin modulation. Users report reduced cramp intensity and better sleep. Dose: individual titration — start with 10–20 mg CBD, 2× daily (see CBD dosing guide).

Endometriosis — evidence & CH reality

Around 190,000 women in Switzerland live with endometriosis. Studies (Sanchez et al., Bouaziz et al.) show ECS dysregulation in endometriotic lesions — CB1/CB2 are aberrantly expressed. THC and CBD inhibit endometrial cell proliferation and modulate pain in lab models.

In practice: medical cannabis can be prescribed for endometriosis in Switzerland — provided standard therapy is exhausted, with prescription and BAG approval. See prescription guide and insurance guide.

Perimenopause & menopause

Between the late 40s and mid-50s the hormonal balance changes fundamentally. Common symptoms: hot flashes, sleep disorders, mood swings, joint pain, libido loss. The ECS is involved in all of these — hence CBD is increasingly discussed as an adjuvant.

Interactions (pill, HRT, antidepressants)

Discreet access to tested CBD varietiesAs a CannabisClub member you get lab-tested CBD flower with full terpene declaration from CHF 1.00–2.50/g — ideal for cyclic use. No shop visit, no small talk, no inflated prices.
Become a member →

Prescription & insurance in Switzerland

Same procedure as for men: medical diagnosis, documented standard-therapy failure, prescription, cost approval where applicable. See insurance guide.

Strain & consumption recommendations

FAQ

Does CBD help with menstrual cramps? Evidence limited but positive; users report clear relief. Titrate individually, 10–20 mg CBD 2× daily to start.

Is medical cannabis approved for endometriosis in Switzerland? Yes, off-label with BAG approval when standard therapy fails.

CBD and contraceptive pill — safe? Usually fine at low doses. High chronic use: consult gynaecologist.

Which strain for menopause? Indica-dominant with high CBD and myrcene/linalool. Add CBN for sleep.

CBD in pregnancy and breastfeeding? No — generally advised against; data insufficient and CBD/THC cross the placenta.

Does health insurance cover it? In individual cases yes, with cost approval.

How do I become a member? Via the waitlist. Sign up here.

Update log